InMed Technologies is the choice for the highest quality, innovative and specific nutraceuticals, nutritional supplements and cosmeceuticals. Designed for the US consumer and practitioner market, InMed aims to consistently raise the standards, evaluating products using the most current and sophisticated analytical procedures. Manufacturing and testing is conducted in cGMP certified and drug licensed facilities, with all products manufactured to FDA compliance. This level of commitment ensures that InMed consistently develop products that you and your patients can trust for quality and effectiveness.
All products are niched, with clinical relevance in mind, specific to the two most important areas in human health: The Human Microbiome and Mitochondrial function. InMed’s primary concern is patient outcome, with a commitment to uphold principles of safety, quality and efficacy at the foundation of our research.
InMed technologies conduct bench work for life science products via Medlab Pty Ltd (www.medlab.co), a publically listed drug discovery and early phase development company, based in Sydney, Australia. Medlab specializes in biologics, targeting; illness, disease states and syndromes. More specifically, Medlab focuses on the role that bacteria play in health and disease and investigates the gastrointestinal microbiome’s ability to modulate the impact of other therapeutic agents. Medlab embraces a unique area of research to develop new medicines in highly sought after areas, specifically: chronic kidney disease, obesity, depression, pain management and anti-aging/muscular-skeletal health.